Shares of Novavax Inc. NVAX, -1.80% slipped 1.80% to $10.89 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +1.90% rising 1.90% to 12,113.79 and the Dow Jones Industrial Average DJIA, +0.78% rising 0.78% to 34,156.69. This was the stock’s third consecutive day of losses. Novavax Inc. closed $84.45 short of its 52-week high ($95.34), which the company achieved on February 10th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, +0.02% rose 0.02% to $163.40, Pfizer Inc. PFE, -0.39% fell 0.39% to $43.59, and Merck & Co. Inc. MRK, +1.59% rose 1.59% to $105.68. Trading volume (5.3 M) remained 2.2 million below its 50-day average volume of 7.5 M.